Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

Sep 11, 2020

30561_dirs_2020-09-10_de250b6b-e569-4584-a98a-91e5b4580e2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-09-08

Reporting Person: Hessekiel Jeffrey (EVP and General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-09-08 Common Stock M 59692 $1.90 Acquired 313692 Direct
2020-09-08 Common Stock M 190000 $6.21 Acquired 503692 Direct
2020-09-08 Common Stock F 160666 $20.71 Disposed 343026 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-09-08 Option (right to buy) $1.9 M 59692 Disposed 2022-02-04 Common Stock (59692.0) Direct
2020-09-08 Option (right to buy) $6.21 M 190000 Disposed 2022-09-15 Common Stock (190000.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 999 Indirect

Footnotes

F1: Includes 39,058 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: Represents a "net exercise" of outstanding stock options. The Reporting Person received 89,026 shares of Common Stock on the net exercise of stock options to purchase 249,692 shares of Common Stock. The Issuer withheld 160,666 shares of Common Stock underlying the stock options for payment of the exercise prices and tax withholdings using a stock price on September 8, 2020 of $20.71.

F3: Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of September 8, 2020.

F4: The option, representing the right to purchase a total of 200,000 shares of Common Stock, became fully exercisable on April 28, 2016.

F5: The option, representing the right to purchase a total of 190,000 shares of Common Stock, became fully exercisable on September 16, 2019.